• Read the Report
  • Contact Us
Global Commission on HIV and the LawGlobal Commission on HIV and the LawGlobal Commission on HIV and the Law
Menu
  • Background
    • HIV and the Law
    • Commission Overview
    • Commissioners
    • Technical Advisory Group
  • Report
    • 2012 Report
    • 2018 Supplement
  • Dialogues
    • Global Dialogue 2018
      • 2018 Supplement
      • Global Dialogue 2018 Videos
    • Global Dialogue 2012
      • Video
      • Photo Gallery
      • Speeches
    • Regional Dialogues
      • Asia-Pacific Regional Dialogue
      • Caribbean
      • Eastern Europe and Central Asia
      • Latin America
      • Africa
      • Middle East and North Africa
      • High Income Countries
      • Civil Society Participation
      • Submissions to the Regional Dialogues
  • Implementation
    • Access to Health Technologies
      • Competition Law Guidance
      • Competition Law Webinar
      • 2022 Supplement
    • Civic Space
    • Digital
      • Guidance on the rights-based and ethical use of digital technologies
    • Programmes
      • Being LGBTI in Asia
      • Challenging stigma and discrimination in the Caribbean
      • Guidance for Prosecutors on HIV-related Criminal Cases
      • Improving SRHR for young key populations in Southern Africa
      • International Guidelines on Human Rights & Drug Policy
      • Multi-Country Western Pacific Integrated HIV/TB Project
      • Promoting a rights-based response to HIV in Africa
      • Removing legal barriers in Africa
      • South Asia Global Fund HIV Programme
      • UHC Legal Solutions Network
    • Follow Up
      • Follow Up Stories
      • Legal Environment Assessments
      • Leave No One Behind: Lessons from the Global Commission on HIV and the Law for Agenda 2030
  • Resources
    • eLibrary
      • Capacity Development Toolkits
      • Fact Sheets
      • Legal Environment Assessments, Reviews and Audits
      • National Dialogue Reports
      • Policy and Issue Briefs
      • Research, Discussion Papers and Reports
    • Evaluation of the Global Commission on HIV & the Law
    • Report & Working Papers
      • Read the Report
      • 2018 Supplement
      • Working Papers
      • Submissions
      • Presentations
      • Articles and Speeches from Commissioners
      • Selected Bibliographies
    • Regional Dialogue Resources
      • Asia-Pacific
      • Caribbean
      • Latin America
      • Eastern Europe and Central Asia
      • Africa
      • High Income Countries
    • HIV and the Law Animated Video
  • News
    • News Articles
    • Press Releases
    • Newsletter Archives
  • #Triple10Targets Campaign
    • Campaign Home
    • Become a Champion
    • Campaign Updates

Op-Ed: Canada’s drug policy is in with the wrong crowd

Share this post

Op-Ed: Canada’s drug policy is in with the wrong crowd

Published on Tuesday, 25 February 2014 17:18
The world’s nations have begun talks ahead of the United Nations General Assembly Special Session on Drugs in 2016. This is a time of increasing high-level calls for drug policy reform and a sense that policies long dominated by prohibition and law enforcement in many parts of the world have failed miserably.

Countries may be better served with a public health policy approach instead. Canada has long been a world leader in implementing harm reduction policy when it comes to drug use at home. So it was almost shocking to see it aligning itself to countries such as Russia and China in vocally opposing the inclusion of “harm reduction” in a new a new set of UN principles that will guide talks at the special session in 2016.

It is a disturbing decision, given the international acknowledgment of Canada’s progressive harm-reduction approach to HIV prevention that has successfully saved thousands of lives. Many of these approaches, such as clean needle and syringe programs and the provision of opioid substitution therapy, are now recommended by the World Health Organization (WHO), the Joint United Nations Program on HIV/AIDS (UNAIDS), and the United Nations Office on Drugs and Crime (UNODC), and have become the gold standard for other countries to replicate.

The evidence from trials and from experience on the ground is comprehensive: harm reduction reduces the risk of acquiring HIV; it decreases mortality among people who inject drugs. The evidence has long been in. Harm reduction interventions were the primary reason that an HIV/AIDS epidemic was avoided among the drug user community in the developed world at the onset of the disease in the 1980s.

Harm reduction interventions also increase the lifelong chances of quitting drugs, decrease delinquency and violence related to drugs, and help re-socialization in the workplace and with family. How can Canada speak out at the UN against the very programs that has made it a world leader in the fight against HIV? It is somewhat ironic that probably the most famous and studied harm-reduction program in the world is in Canada.

Insite, Vancouver’s supervised injection site, is a facility where addicts can inject street drugs under the protective gaze of a nurse. Since it opened 10 years ago, more than one million injections have taken place at Insite. Fatal overdose rates dropped 35 per cent in the neighbourhood, and thousands of people have been connected to detox and drug treatment options, housing and employment, and health services like HIV and hepatitis C treatment.

Throughout, not a single needle has been shared, meaning no one has contracted, or transmitted, HIV at Insite. As a result of services like Insite, Vancouver has become the only jurisdiction in the world to demonstrate dramatic decreases in HIV among its injection drug-using populations. However, Canada’s current federal government has done everything in its power to close the facility, and to prevent others from opening.

In 2007, Canada expunged the words “harm reduction” from its National Drugs Strategy, and in taking an anti-harm reduction stance at the United Nations last month, Canada has joined ranks with member states that equally oppose harm reduction, including Russia — the country with the world’s fastest-growing HIV epidemics among people who inject drugs. While UNAIDS reports that annual HIV infections are dropping worldwide, Russia is seeing its rates climb: More than one million people, or about one in one hundred, are living with HIV.

That figure was around 250,000 only a decade ago. Sixty per cent of all new infections in Russia come from needles used and reused to inject drugs. This number grows by about 200 new cases every single day, meaning that Russia is spreading HIV five times faster than the global average. As the UN Secretary-General’s Special Envoy for HIV/AIDS in Eastern Europe and Central Asia and as a scientist, I and my colleagues who work in the field have seen countless examples over the past three decades where harm reduction interventions, of the kind that exist in Canada, have successfully prevented an HIV epidemic among people who use drugs in so many countries.

On so many levels it is disappointing to see Canada — a country that was formerly a defender of harm reduction and human rights in the international system — turn its back on the very approaches to HIV prevention that it has helped pioneer, and that hold the potential to save millions of lives worldwide.

Michel Kazatchkine is the UN Secretary-General’s Special Envoy on HIV/AIDS in Eastern Europe and Central Asia.  

Source: Ottawa Citizen

Recent Posts

  • Tried and tested: Effective strategies for the HIV response begin with communities
  • Two thirds of countries now do not criminalize same-sex sex
  • Participation of LGBTI+ persons in political and electoral processes helps to build stronger democracies
  • Six Southeast Asian countries collaborate on HIV stigma and discrimination reduction
  • New legal principles launched on International Women’s Day to advance decriminalization efforts

© 2017 [blog-link], All Rights Reserved.